Samjin Pharmaceuticals Co., Ltd. (005500.KS)
KRW 18280.0
(-0.33%)
KRW 18280.0
(-0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.33 Billion | 17.29 Billion | 23.96 Billion | 23.86 Billion | 23.63 Billion | 30.08 Billion |
| Net Income | 18.9 Billion | 21.9 Billion | 28.4 Billion | 27.87 Billion | 11.88 Billion | 25.52 Billion |
| Depreciation & Amortization | 16.61 Billion | 9.81 Billion | 7.36 Billion | 6.49 Billion | 6.47 Billion | 6.25 Billion |
| Deferred income taxes | - | - | - | 5.79 Billion | 357.05 Million | 8.44 Billion |
| Stock-based compensation | - | - | - | 713.44 Million | 882.56 Million | 906.12 Million |
| Change in working capital | -27.3 Billion | -12.5 Billion | -19.92 Billion | -16.71 Billion | 4.42 Billion | -10.47 Billion |
| Other non-cash items | 113.44 Million | -1.91 Billion | 8.12 Billion | -302.18 Million | -382.05 Million | -580.8 Million |
| Investing Cash Flow | -18.24 Billion | -70.05 Billion | -71.55 Billion | -32.17 Billion | -11.78 Billion | -6.62 Billion |
| Investments in PPE | -20.72 Billion | -35.49 Billion | -74.6 Billion | -30.59 Billion | -12.03 Billion | -8.23 Billion |
| Acquisitions | 398.56 Million | -39.55 Billion | 1.67 Billion | -1.49 Billion | -3.05 Billion | 309.18 Million |
| Investment purchases | -761.76 Million | -8.97 Billion | -4.8 Billion | -7.24 Billion | -5.34 Billion | -5.73 Billion |
| Sales/Maturities of investments | 2.91 Billion | 12.98 Billion | 5.8 Billion | 6.48 Billion | 5.34 Billion | 7.14 Billion |
| Other Investing Activities | -73.4 Million | 983.05 Million | 368.58 Million | 683.3 Million | 3.3 Billion | -112.94 Million |
| Financing Cash Flow | 9.97 Billion | 47.16 Billion | 36.61 Billion | -4.66 Billion | -10.64 Billion | -14.66 Billion |
| Debt repayment | -31.16 Billion | -45.79 Billion | -13.43 Billion | -1.02 Billion | -440.64 Million | -4 Billion |
| Dividends payments | -10.58 Billion | -9.84 Billion | -9.84 Billion | -9.84 Billion | -9.84 Billion | -9.84 Billion |
| Common Stock Repurchased | -9.99 Billion | -4.99 Billion | - | - | - | - |
| Common Stock Issuance | -715.79 Million | 29.99 Billion | - | - | - | - |
| Other Financing Activities | 62.43 Billion | 77.79 Billion | 59.9 Billion | 6.2 Billion | -364.61 Million | -825.07 Million |
| Accounts receivables | -2.45 Billion | -2.44 Billion | -6.69 Billion | 2.44 Billion | 11.62 Billion | 11.63 Billion |
| Accounts payables | -2.04 Billion | 944.25 Million | -473.87 Million | -2.95 Billion | -2.28 Billion | -3.47 Billion |
| Inventory | -12.97 Billion | 1.11 Billion | 355.98 Million | -12.03 Billion | 3.69 Billion | -10.28 Billion |
| Other working capital | -9.82 Billion | -12.12 Billion | -13.11 Billion | -4.16 Billion | -8.61 Billion | -184.22 Million |
| Cash at beginning of period | 2.34 Billion | 7.94 Billion | 18.9 Billion | 31.89 Billion | 30.69 Billion | 21.91 Billion |
| Cash at end of period | 2.4 Billion | 2.34 Billion | 7.94 Billion | 18.9 Billion | 31.89 Billion | 30.69 Billion |
| Capital Expenditure | -20.72 Billion | -35.49 Billion | -74.6 Billion | -30.59 Billion | -12.03 Billion | -8.23 Billion |
| Effect of forex changes on cash | -36.82 Thousand | 10.00 | - | - | - | - |
| Net cash flow / Change in cash | 60.01 Million | -5.59 Billion | -10.96 Billion | -12.98 Billion | 1.19 Billion | 8.78 Billion |
| Free Cash Flow | -12.38 Billion | -18.2 Billion | -50.63 Billion | -6.73 Billion | 11.59 Billion | 21.84 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 24.79 Billion | 3.09 Billion | 18.9 Billion | 7.37 Billion | 3.14 Billion | -374.43 Million |
| Depreciation & Amortization | 3.84 Billion | 4.86 Billion | 16.61 Billion | 4.37 Billion | 4.38 Billion | 4.33 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -13.6 Billion | 5.67 Billion | -27.3 Billion | -4.03 Billion | -8.19 Billion | -4.64 Billion |
| Other non-cash items | 15.59 Billion | 3.12 Billion | 113.44 Million | -338.28 Million | 2.21 Billion | -315.94 Million |
| Investing Cash Flow | -6.09 Billion | -2.98 Billion | -18.24 Billion | -13.51 Billion | 1.33 Billion | 473.25 Million |
| Investments in PPE | -5.86 Billion | -3.04 Billion | -20.72 Billion | -13.68 Billion | -1.73 Billion | -2.77 Billion |
| Acquisitions | 45.5 Million | 200 Million | 398.56 Million | -37.53 Million | 31 Million | 27.67 Million |
| Investment purchases | -246.54 Million | -1.14 Billion | -761.76 Million | 9.86 Billion | -158.55 Million | -5.19 Billion |
| Sales/Maturities of investments | -22.64 Million | 900 Million | 2.91 Billion | -9.65 Billion | 3.25 Billion | 8.04 Billion |
| Other Investing Activities | -1.56 Million | 105.45 Million | -73.4 Million | 644 Thousand | -57.79 Million | 379.57 Million |
| Financing Cash Flow | -12.5 Billion | -7.75 Billion | 9.97 Billion | 6.13 Billion | -3.31 Billion | 999.38 Million |
| Debt repayment | -2.91 Billion | -7.58 Billion | -31.16 Billion | -6.41 Billion | -40.08 Billion | -33.08 Billion |
| Dividends payments | -10.21 Billion | - | -10.58 Billion | -116.2 Thousand | - | -10.58 Billion |
| Common Stock Repurchased | -4.99 Billion | - | -9.99 Billion | - | -3.24 Billion | -6.01 Billion |
| Common Stock Issuance | - | - | -715.79 Million | - | - | 10.58 Billion |
| Other Financing Activities | -200.24 Million | - | 62.43 Billion | 12.55 Billion | 40.01 Billion | 40.1 Billion |
| Accounts receivables | 511.72 Million | 4.06 Billion | -2.45 Billion | -4.15 Billion | -734.06 Million | 66.59 Million |
| Accounts payables | 1.63 Billion | 4.79 Billion | -2.04 Billion | -7.41 Billion | 2.4 Billion | -455.79 Million |
| Inventory | -3.08 Billion | -1.74 Billion | -12.97 Billion | 4.21 Billion | -8.83 Billion | -4.04 Billion |
| Other working capital | -12.67 Billion | -1.43 Billion | -9.82 Billion | 3.32 Billion | -1.02 Billion | -212.53 Million |
| Cash at beginning of period | 5.8 Billion | 2.4 Billion | 2.34 Billion | 2.39 Billion | 2.82 Billion | 2.35 Billion |
| Cash at end of period | 9.21 Billion | 5.8 Billion | 2.4 Billion | 2.4 Billion | 2.39 Billion | 2.82 Billion |
| Capital Expenditure | -5.86 Billion | -3.04 Billion | -20.72 Billion | -13.68 Billion | -1.73 Billion | -2.77 Billion |
| Effect of forex changes on cash | - | - | -36.82 Thousand | 36.82 Thousand | 10.00 | -36.84 Thousand |
| Net cash flow / Change in cash | 3.4 Billion | 3.4 Billion | 60.01 Million | 3.38 Million | -425.01 Million | 470.52 Million |
| Free Cash Flow | 16.13 Billion | 11.09 Billion | -12.38 Billion | -6.3 Billion | -182.22 Million | -3.77 Billion |
MPHASIS
1817
ALLWF
600012
002324
LIBERTSHOE